We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACB icon
5001
PUT
Pacific Biosciences
PACB
$422M
-6,500
Closed -$227K
PATH icon
5002
UiPath
PATH
$5.62B
-167,383
Closed -$11.4M
PBF icon
5003
PBF Energy
PBF
$7.29B
-894,549
Closed -$9.28M
PCG icon
5004
PG&E
PCG
$47.8B
-840,060
Closed -$7.93M
PD icon
5005
PUT
PagerDuty
PD
$700M
-30,000
Closed -$1.28M
PFGC icon
5006
Performance Food Group
PFGC
$17.5B
-544,708
Closed -$26.4M
PFLT icon
5007
PennantPark Floating Rate Capital
PFLT
$681M
-34,901
Closed -$444K
PHM icon
5008
CALL
Pultegroup
PHM
$24.5B
-32,400
Closed -$1.77M
PJT icon
5009
PJT Partners
PJT
$4.37B
-18,387
Closed -$1.31M
PLSE icon
5010
Pulse Biosciences
PLSE
$2.09B
-17,528
Closed -$287K
PM icon
5011
CALL
Philip Morris
PM
$301B
-42,400
Closed -$4.2M
PMT
5012
PennyMac Mortgage Investment
PMT
$849M
-21,067
Closed -$444K
PODD icon
5013
PUT
Insulet
PODD
$11.3B
-10,000
Closed -$2.75M
POWW icon
5014
Outdoor Holding Co
POWW
$239M
-250,102
Closed -$2.45M
PRAX icon
5015
Praxis Precision Medicines
PRAX
$9.07B
-3,018
Closed -$827K
PRPL icon
5016
Purple Innovation
PRPL
$33.2M
-4,152
Closed -$2.74M
PSFE icon
5017
Paysafe
PSFE
$407M
-7,672
Closed -$1.11M
PSTL
5018
Postal Realty Trust
PSTL
$723M
-25,311
Closed -$462K
PUK icon
5019
Prudential
PUK
$36.5B
-35,353
Closed -$1.31M
HTT
5020
High Templar Tech Ltd
HTT
$377M
-15,377
Closed -$37K
R icon
5021
PUT
Ryder
R
$10.3B
-3,400
Closed -$253K
RARE icon
5022
CALL
Ultragenyx Pharmaceutical
RARE
$2.65B
-24,200
Closed -$2.31M
RBA icon
5023
CALL
RB Global
RBA
$20.8B
-16,000
Closed -$948K
RBA icon
5024
RB Global
RBA
$20.8B
-188,911
Closed -$11.2M
RBOT
5025
DELISTED
Vicarious Surgical
RBOT
-11,188
Closed -$3.35M

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.